Science and Research

The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say

Researchers say their intention isn't to fearmonger, but to educate the public on potential risks

Concerns were raised that cannabis would spike accidents, especially among youth, but data show otherwise

The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas

According to Canadian researchers, cannabis can help people cut the country's most fatal dependency

A 5-year project led by university researchers will study pot as a treatment for opioid use and dependency on methadone or suboxone

In a new study, two popular detection devices never mistook CBD for THC

Surveys from pre- and post-legalization show that heavy consumers are less likely to buy legal Canadian weed due to cost and access

By perpetuating false narratives about fentanyl, lives are put at risk, advocates argue

Researchers are looking at the potential pros and cons of cannabis use on procreative fitness

An international team of scientists discovered that all modern-day pot evolved from 'basal cannabis', first smoked in ancient China more than 12,000 years ago

Current naming conventions have added confusion to the poorly understood genetic background of the thousands of varieties in existence today

The psychedelic movement is no longer about anecdotes, experts say

Results come from the IMAGEN study, a large sample group tracked over time in 4 European countries

Cannabis smokers inhale 'significantly' less harmful chemicals than tobacco smokers, but are still not without some risk

After drinking the psychedelic plant brew together, Jewish-Israeli and Arab-Palestinian participants reported moments of deep connection, unity and oneness

Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA

Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims

Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy

Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest

More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour

The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine

The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to talk about

Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof says

It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials

Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off

A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy

Maine-based Desert Harvest is working with university researchers to see if its CBD-aloe vera formula can treat pain more safely and effectively than opioids

In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications

With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field

From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high

Brock University's Michael Armstrong argues Canada's restrictive labelling rules incentivize producers to maximize THC content and minimize price

Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine

A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound

Lead researcher and Tilray VP Philippe Lucas says new data shows why Canada regulating weed on par with alcohol would reduce societal harms

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Results should be used by policy makers to save lives during the overdose crisis, says cannabis and addiction scientist M-J Milloy

A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market

Avail Cannabis clinic will monitor 30 veterans from Ont. or Man. for 3 months to see if symptoms improve

Director and producer David Jakubovic says stigma can be broken with just 5 minutes of being open to science